Literature DB >> 15187127

Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG.

Francois-Xavier Hubert1, Cécile Voisine, Cédric Louvet, Michèle Heslan, Régis Josien.   

Abstract

We have identified in the rat a new subset of MHC class II(+) CD4(+)CD3(-)CD11b(-) leukocytes that produce high amounts of type I IFN upon viral stimulation and that appeared homologous to plasmacytoid DC (pDC) previously described in humans and mice. These cells exhibited the following phenotype: CD5(+),CD90(+),CD45R(+),CD45RC(+),CD11c(-),CD161a(+),CD200(+),CD172a(+),CD32(+),CD86(+). Rat pDC did not express the DC-specific marker OX62 and were more abundant in the spleen than the classical CD4(+) and CD4(-) subsets of OX62(+)CD11b(+) DC we previously described that produced very little, if any, type I IFN. Spleen pDC exhibited an undifferentiated morphology and rapidly died in vitro, but showed extensive dendrite formation, survival, maturation, and moderate type I IFN production upon stimulation by oligonucleotides containing type B CpG motifs (CpG ODN). Type A CpG ODN and CD40 ligand induced pDC to produce large amounts of type I IFN, but did not promote maturation. CpG ODN and CD40 ligand, but not influenza virus, induced IL-12p40 and IL-6 secretion. Spleen pDC did not produce IL-12p70, TNF-alpha, IL-1beta, or IL-10 using these stimulation conditions. Correlating with their strong responsiveness to virus and CpG ODN, rat pDC specifically expressed Toll-like receptor 7 and 9 mRNA. Fresh spleen pDC were poor stimulators of allogenic CD4(+) and CD8(+) T cells, but became potent inducers of allogenic T cell proliferation as well as Th1 differentiation after stimulation by type B CpG. Therefore, rat pDC appear very similar to human pDC, indicating that the specific phenotype and functions of pDC have been highly conserved between species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187127     DOI: 10.4049/jimmunol.172.12.7485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.

Authors:  Yohei Mineharu; Gwendalyn D King; A K M G Muhammad; Serguei Bannykh; Kurt M Kroeger; Chunyan Liu; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis.

Authors:  Peter J Wermuth; Sergio A Jimenez
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

3.  Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.

Authors:  Flavia De Bernardis; Roberta Lucciarini; Maria Boccanera; Consuelo Amantini; Silvia Arancia; Stefania Morrone; Michela Mosca; Antonio Cassone; Giorgio Santoni
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

5.  Autonomic renal denervation ameliorates experimental glomerulonephritis.

Authors:  Roland Veelken; Eva-Maria Vogel; Karl Hilgers; Kerstin Amann; Andrea Hartner; Gabriele Sass; Winfried Neuhuber; Gisa Tiegs
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

6.  The stress protein gp96 is not an activator of resting rat bone marrow-derived dendritic cells, but is a costimulator and activator of CD3+ T cells.

Authors:  Shabana Mirza; Munitta Muthana; Barbara Fairburn; Laura K Slack; Kay Hopkinson; A Graham Pockley
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

7.  New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy.

Authors:  S Remy; L Tesson; C Usal; S Menoret; V Bonnamain; V Nerriere-Daguin; J Rossignol; C Boyer; T H Nguyen; P Naveilhan; L Lescaudron; I Anegon
Journal:  Transgenic Res       Date:  2010-01-22       Impact factor: 2.788

8.  A non-receptor-mediated mechanism for internalization of molecular chaperones.

Authors:  A Graham Pockley; Barbara Fairburn; Shabana Mirza; Laura K Slack; Kay Hopkinson; Munitta Muthana
Journal:  Methods       Date:  2007-11       Impact factor: 3.608

Review 9.  Post-transcriptional regulation of interferons and their signaling pathways.

Authors:  Ram Savan
Journal:  J Interferon Cytokine Res       Date:  2014-04-04       Impact factor: 2.607

10.  Imiquimod-induced CCR9 Ameliorates murine TNBS Colitis.

Authors:  Ryoma Suzuki; Kyoko Katakura; Tatsuo Fujiwara; Naohiko Gunji; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2016-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.